文献速递妇产影像泌尿生殖PETMR

子宫内膜癌中的PET/MRI:影像生物标志物与疾病进展及总生存相关

PET/MRI in Endometrial Cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival.
PubMed 文献 · Acad Radiol · 2023-09-14

这项前瞻性研究于2014年4月至2016年4月纳入88例新诊断子宫内膜癌患者行[18F]氟脱氧葡萄糖PET/MRI,其中69例肿瘤可测量者纳入图像分析;中位随访80个月后15例(22%)进展、6例(9%)死亡,原发肿瘤MTV和TLG较高者无进展生存期和总生存期均显著缩短,多因素分析中MTV是无进展生存期的独立预测因子。

要点

  • 原发肿瘤MTV和TLG较高者无进展生存期显著缩短(P < 0.001,P < 0.001),总生存期也显著缩短(P = 0.048,P = 0.034)。
  • 多因素分析中MTV是无进展生存期的独立预测因子(风险比 = 10.84,P = 0.033)。
  • ADCmin、ADCmean和SUVmax与无进展生存期及总生存期均无显著关联。

核心结论

  • PET/MRI生物标志物,尤其是MTV和TLG,与子宫内膜癌患者的无进展生存期和总生存期相关。
  • MTV是无进展生存期的独立预测因子。

研究设计与样本

  • 前瞻性研究,2014年4月至2016年4月纳入88例新诊断子宫内膜癌患者行[18F]氟脱氧葡萄糖PET/MRI,其中69例PET/MRI上肿瘤可测量者纳入图像分析。
  • 影像生物标志物包括原发肿瘤的最小和平均表观扩散系数(ADCmin和ADCmean)、最大标准化摄取值(SUVmax)、代谢肿瘤体积(MTV)和总病灶糖酵解(TLG)。
  • 采用对数秩检验和Cox比例风险模型评估影像生物标志物与生存的关系。

诊断标准与关键数值

  • 中位随访80个月后,15例(22%)患者肿瘤进展,6例(9%)患者死亡。
  • 原发肿瘤MTV较高者无进展生存期显著缩短(P < 0.001),TLG较高者无进展生存期显著缩短(P < 0.001)。
  • 原发肿瘤MTV较高者总生存期显著缩短(P = 0.048),TLG较高者总生存期显著缩短(P = 0.034)。
  • 多因素分析中MTV是无进展生存期的独立预测因子(风险比 = 10.84,P = 0.033)。
  • ADCmin、ADCmean和SUVmax与无进展生存期及总生存期均无显著关联。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

RATIONALE AND OBJECTIVES: To evaluate the association between positron emission tomography (PET)/magnetic resonance imaging (MRI) biomarkers and survival outcomes in patients with endometrial cancer.

MATERIALS AND METHODS: Between April 2014 and April 2016, 88 patients with newly diagnosed endometrial cancer participated this prospective study and underwent [18F] fluorodeoxyglucose PET/MRI. Sixty-nine patients with measurable tumors on PET/MRI were included in the image analysis. Imaging biomarkers included the minimum and mean apparent diffusion coefficients (ADCmin and ADCmean), maximum standardized uptake value (SUVmax), metabolic tumor volume (MTV), and total lesion glycolysis (TLG) of the primary tumors. The log-rank test and Cox proportional hazards model were used to assess the relationship between imaging biomarkers and survival.

RESULTS: After a median follow-up of 80 months, 15 (22%) patients had tumor progression and six (9%) patients died. The results of ADCmin, ADCmean, and SUVmax did not show a significant association with progression-free survival (PFS) and overall survival (OS). Significantly shorter PFS was noted in patients with primary tumors with higher MTV (P < 0.001) and TLG (P < 0.001). Significantly shorter OS was also noted in patients with primary tumors with higher MTV (P = 0.048) and TLG (P = 0.034). In the multivariate analysis, MTV was an independent predictor of PFS (hazard ratio = 10.84, P = 0.033).

CONCLUSION: PET/MRI biomarkers, particularly MTV and TLG, are associated with PFS and OS in patients with endometrial cancer. MTV was an independent predictor of PFS.

来源:Acad Radiol,查看原文。版权归原作者所有。

引用

  1. Shih IL, Yen RF, Chen CA, et al. PET/MRI in Endometrial Cancer: Imaging Biomarkers are Associated with Disease Progression and Overall Survival. Acad Radiol. 2023. PMID: 37714718. doi:10.1016/j.acra.2023.08.012

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。